359 related articles for article (PubMed ID: 20603199)
1. Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum.
Fatmawati S; Shimizu K; Kondo R
Fitoterapia; 2010 Dec; 81(8):1033-6. PubMed ID: 20603199
[TBL] [Abstract][Full Text] [Related]
2. A new lanostane-type triterpene from the fruiting bodies of Ganoderma lucidum.
Luo J; Zhao YY; Li ZB
J Asian Nat Prod Res; 2002 Jun; 4(2):129-34. PubMed ID: 12067158
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors.
Fatmawati S; Shimizu K; Kondo R
Bioorg Med Chem Lett; 2011 Dec; 21(24):7295-7. PubMed ID: 22047696
[TBL] [Abstract][Full Text] [Related]
4. Structure elucidation and complete NMR spectral assignments of three new lanostanoid triterpenes with unprecedented Delta(16, 17) double bond from Ganoderma lucidum.
Guan SH; Yang M; Wang XM; Xia JM; Zhang ZM; Liu X; Guo DA
Magn Reson Chem; 2007 Sep; 45(9):789-91. PubMed ID: 17640004
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of aldose reductase in vitro by constituents of Ganoderma lucidum.
Fatmawati S; Shimizu K; Kondo R
Planta Med; 2010 Oct; 76(15):1691-3. PubMed ID: 20379959
[TBL] [Abstract][Full Text] [Related]
6. New triterpenoids from the fruiting bodies of Ganoderma lucidum and their bioactivities.
Liu DZ; Zhu YQ; Li XF; Shan WG; Gao PF
Chem Biodivers; 2014 Jun; 11(6):982-6. PubMed ID: 24934684
[TBL] [Abstract][Full Text] [Related]
7. Ganoderol B: a potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum.
Fatmawati S; Shimizu K; Kondo R
Phytomedicine; 2011 Sep; 18(12):1053-5. PubMed ID: 21596546
[TBL] [Abstract][Full Text] [Related]
8. Lanostane triterpenes from the fruiting bodies of Ganoderma lucidum and their inhibitory effects on adipocyte differentiation in 3T3-L1 Cells.
Lee I; Seo J; Kim J; Kim H; Youn U; Lee J; Jung H; Na M; Hattori M; Min B; Bae K
J Nat Prod; 2010 Feb; 73(2):172-6. PubMed ID: 20039640
[TBL] [Abstract][Full Text] [Related]
9. [Studies on the ganoderic acid, a new constituents from the fruiting body of Ganoderma lucidum (Fr.) Karst].
Wang FS; Cai H; Yang JS; Zhang YM; Hou CY; Liu JQ; Zhao MJ
Yao Xue Xue Bao; 1997 Jun; 32(6):447-50. PubMed ID: 11596326
[TBL] [Abstract][Full Text] [Related]
10. A new triterpene from the fruiting bodies of Ganoderma lucidum.
Chen M; Zhang M; Sun S; Xia B; Zhang HQ
Yao Xue Xue Bao; 2009 Jul; 44(7):768-70. PubMed ID: 19806918
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect on NO production of triterpenes from the fruiting bodies of Ganoderma lucidum.
Tung NT; Cuong TD; Hung TM; Lee JH; Woo MH; Choi JS; Kim J; Ryu SH; Min BS
Bioorg Med Chem Lett; 2013 Mar; 23(5):1428-32. PubMed ID: 23357630
[TBL] [Abstract][Full Text] [Related]
12. Steroids and triterpenes from the fruit bodies of Ganoderma lucidum and their anti-complement activity.
Seo HW; Hung TM; Na M; Jung HJ; Kim JC; Choi JS; Kim JH; Lee HK; Lee I; Bae K; Hattori M; Min BS
Arch Pharm Res; 2009 Nov; 32(11):1573-9. PubMed ID: 20091270
[TBL] [Abstract][Full Text] [Related]
13. Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum.
Lee I; Ahn B; Choi J; Hattori M; Min B; Bae K
Bioorg Med Chem Lett; 2011 Nov; 21(21):6603-7. PubMed ID: 21924611
[TBL] [Abstract][Full Text] [Related]
14. [Extraction of triterpenoids from fruiting [corrected] bodies of Ganoderma lucidum by supercritical fluid extraction].
Song SH; Jia XB; Chen Y; Chen B; Wang LJ; Zhao CL
Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(17):2104-7. PubMed ID: 19066051
[TBL] [Abstract][Full Text] [Related]
15. Lanostane triterpenes from Ganoderma lucidum suppress the adipogenesis in 3T3-L1 cells through down-regulation of SREBP-1c.
Lee I; Kim J; Ryoo I; Kim Y; Choo S; Yoo I; Min B; Na M; Hattori M; Bae K
Bioorg Med Chem Lett; 2010 Sep; 20(18):5577-81. PubMed ID: 20702092
[TBL] [Abstract][Full Text] [Related]
16. Triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH.
Lin YX; Sun JT; Liao ZZ; Sun Y; Tian XG; Jin LL; Wang C; Leng AJ; Zhou J; Li DW
Fitoterapia; 2022 Apr; 158():105161. PubMed ID: 35217118
[TBL] [Abstract][Full Text] [Related]
17. Anticomplement activity of terpenoids from the spores of Ganoderma lucidum.
Min BS; Gao JJ; Hattori M; Lee HK; Kim YH
Planta Med; 2001 Dec; 67(9):811-4. PubMed ID: 11745016
[TBL] [Abstract][Full Text] [Related]
18. Triterpenoids from Ganoderma lucidum and their cytotoxic activities.
Li P; Deng YP; Wei XX; Xu JH
Nat Prod Res; 2013; 27(1):17-22. PubMed ID: 22263904
[TBL] [Abstract][Full Text] [Related]
19. 5alpha-reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum.
Liu J; Kurashiki K; Shimizu K; Kondo R
Biol Pharm Bull; 2006 Feb; 29(2):392-5. PubMed ID: 16462054
[TBL] [Abstract][Full Text] [Related]
20. Constituents from the fruiting bodies of Ganoderma applanatum and their aldose reductase inhibitory activity.
Lee SH; Shim SH; Kim JS; Kang SS
Arch Pharm Res; 2006 Jun; 29(6):479-83. PubMed ID: 16833015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
